Oesophageal cancer
Results
Phase 2/3
This trial was looking at a drug called cetuximab alongside chemotherapy and radiotherapy for cancer of the food pipe (oesophageal cancer). The trial was supported by Cancer Research UK.
If oesophageal cancer has not spread to other parts of your body, your doctors may suggest that you have a combination of chemotherapy and radiotherapy. This is called chemoradiotherapy.
This trial looked at having cetuximab as well as chemoradiotherapy. Cetuximab is a type of biological therapy, called a monoclonal antibody.
The aims of the trial were to
See if adding cetuximab to chemoradiotherapy helped people with oesophageal cancer
Learn more about the side effects
Recruitment start: 7 February 2008
Recruitment end: 22 February 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Tom Crosby
Cancer Research UK
Department of Health
Health and Care Research Wales
Medical Research Council (MRC)
Merck Serono UK
National Institute for Health Research Cancer Research Network (NCRN)
Velindre NHS Trust
Wales Cancer Trials Unit
This is Cancer Research UK trial number CRUK/07/003.
Last reviewed: 17 Sept 2013
CRUK internal database number: 797
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
